意大利阻止25万剂阿斯利康新冠疫苗出口澳洲

2021-03-05 JACKZHAO MedSci原创

欧盟对新冠疫苗的全球供应进行了首次干预,据报道欧盟成员国意大利周四扣押了将运往澳大利亚的阿斯利康-牛津新冠疫苗。

△图片来自安莎社

ANSHA

昨天,欧盟对新冠疫苗的全球供应进行了首次干预,据报道欧盟成员国意大利周四扣押了将运往澳大利亚的阿斯利康-牛津新冠疫苗。

路透社,《金融时报》等媒体此前援引多个信息源称,英国制药巨头阿斯利康已经请求罗马批准从其意大利阿纳格尼工厂运送约25万剂疫苗至澳大利亚,但遭到意大利政府拒绝。目前,阿斯利康、欧盟或意大利外交部发言人没有立即对此事发表评论。

1月,在与阿斯利康发生争执以及供应问题扩大之后,欧盟对欧盟内部生产的疫苗的出口实行了临时管制。批评者将其描述为缓慢推出新冠疫苗,欧盟一直承受着压力。负责疫苗采购协议机构欧盟委员会因未能获得足够的疫苗而受到指责,该地区的医疗机构因批准时间过长而其他地方开绿灯而广受批评。

这些控制措施将持续到三月底,并赋予欧盟成员国权力,如果疫苗生产商不履行合同,则可拒绝批准出口。2月26日意大利政府通知欧盟委员会,该国决定阻止一个批次的阿斯利康疫苗出口到澳大利亚。同一天,欧盟对意方的行动表示同意,意大利成为欧盟首个禁止新冠疫苗出口的国家。

1月,阿斯利康(AstraZeneca)表示,由于其荷兰和比利时工厂的生产问题,春季将向欧盟提供的剂量比最初预期的要少得多。1月31日,该公司随后表示将在第一季度再提供900万剂,以弥补这一缺口。目前欧盟至今只有8%的人口接种了新冠疫苗。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1677039, encodeId=c5aa16e70392e, content=<a href='/topic/show?id=206366e4077' target=_blank style='color:#2F92EE;'>#澳洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66740, encryptionId=206366e4077, topicName=澳洲)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8d027423047, createdName=huangdf, createdTime=Tue Jun 01 07:52:12 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950861, encodeId=f085950861a4, content=非常感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200815/567eec2d6b074163be1d5e1d9226b578/9c20a5fef2764c169c6ac9bf44997ee8.jpg, createdBy=7d5a5410735, createdName=Ably冰, createdTime=Wed Mar 24 21:44:35 CST 2021, time=2021-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1385476, encodeId=0ec213854e63c, content=<a href='/topic/show?id=c31c5322844' target=_blank style='color:#2F92EE;'>#意大利#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53228, encryptionId=c31c5322844, topicName=意大利)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ae503, createdName=pps20019, createdTime=Sat Mar 06 23:52:12 CST 2021, time=2021-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029185, encodeId=dd511029185a5, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Mar 05 11:52:12 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945649, encodeId=f3a4945649da, content=疫苗争夺战, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/df01a4bfb64246379ddfef3370d04115/e1274c8eb5e440918f56f83bcfea9031.jpg, createdBy=3a345397082, createdName=Jessica, createdTime=Fri Mar 05 09:31:29 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945632, encodeId=30ac94563257, content=各保自身, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Fri Mar 05 09:02:36 CST 2021, time=2021-03-05, status=1, ipAttribution=)]
    2021-06-01 huangdf
  2. [GetPortalCommentsPageByObjectIdResponse(id=1677039, encodeId=c5aa16e70392e, content=<a href='/topic/show?id=206366e4077' target=_blank style='color:#2F92EE;'>#澳洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66740, encryptionId=206366e4077, topicName=澳洲)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8d027423047, createdName=huangdf, createdTime=Tue Jun 01 07:52:12 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950861, encodeId=f085950861a4, content=非常感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200815/567eec2d6b074163be1d5e1d9226b578/9c20a5fef2764c169c6ac9bf44997ee8.jpg, createdBy=7d5a5410735, createdName=Ably冰, createdTime=Wed Mar 24 21:44:35 CST 2021, time=2021-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1385476, encodeId=0ec213854e63c, content=<a href='/topic/show?id=c31c5322844' target=_blank style='color:#2F92EE;'>#意大利#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53228, encryptionId=c31c5322844, topicName=意大利)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ae503, createdName=pps20019, createdTime=Sat Mar 06 23:52:12 CST 2021, time=2021-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029185, encodeId=dd511029185a5, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Mar 05 11:52:12 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945649, encodeId=f3a4945649da, content=疫苗争夺战, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/df01a4bfb64246379ddfef3370d04115/e1274c8eb5e440918f56f83bcfea9031.jpg, createdBy=3a345397082, createdName=Jessica, createdTime=Fri Mar 05 09:31:29 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945632, encodeId=30ac94563257, content=各保自身, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Fri Mar 05 09:02:36 CST 2021, time=2021-03-05, status=1, ipAttribution=)]
    2021-03-24 Ably冰

    非常感谢

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1677039, encodeId=c5aa16e70392e, content=<a href='/topic/show?id=206366e4077' target=_blank style='color:#2F92EE;'>#澳洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66740, encryptionId=206366e4077, topicName=澳洲)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8d027423047, createdName=huangdf, createdTime=Tue Jun 01 07:52:12 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950861, encodeId=f085950861a4, content=非常感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200815/567eec2d6b074163be1d5e1d9226b578/9c20a5fef2764c169c6ac9bf44997ee8.jpg, createdBy=7d5a5410735, createdName=Ably冰, createdTime=Wed Mar 24 21:44:35 CST 2021, time=2021-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1385476, encodeId=0ec213854e63c, content=<a href='/topic/show?id=c31c5322844' target=_blank style='color:#2F92EE;'>#意大利#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53228, encryptionId=c31c5322844, topicName=意大利)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ae503, createdName=pps20019, createdTime=Sat Mar 06 23:52:12 CST 2021, time=2021-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029185, encodeId=dd511029185a5, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Mar 05 11:52:12 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945649, encodeId=f3a4945649da, content=疫苗争夺战, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/df01a4bfb64246379ddfef3370d04115/e1274c8eb5e440918f56f83bcfea9031.jpg, createdBy=3a345397082, createdName=Jessica, createdTime=Fri Mar 05 09:31:29 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945632, encodeId=30ac94563257, content=各保自身, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Fri Mar 05 09:02:36 CST 2021, time=2021-03-05, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1677039, encodeId=c5aa16e70392e, content=<a href='/topic/show?id=206366e4077' target=_blank style='color:#2F92EE;'>#澳洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66740, encryptionId=206366e4077, topicName=澳洲)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8d027423047, createdName=huangdf, createdTime=Tue Jun 01 07:52:12 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950861, encodeId=f085950861a4, content=非常感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200815/567eec2d6b074163be1d5e1d9226b578/9c20a5fef2764c169c6ac9bf44997ee8.jpg, createdBy=7d5a5410735, createdName=Ably冰, createdTime=Wed Mar 24 21:44:35 CST 2021, time=2021-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1385476, encodeId=0ec213854e63c, content=<a href='/topic/show?id=c31c5322844' target=_blank style='color:#2F92EE;'>#意大利#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53228, encryptionId=c31c5322844, topicName=意大利)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ae503, createdName=pps20019, createdTime=Sat Mar 06 23:52:12 CST 2021, time=2021-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029185, encodeId=dd511029185a5, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Mar 05 11:52:12 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945649, encodeId=f3a4945649da, content=疫苗争夺战, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/df01a4bfb64246379ddfef3370d04115/e1274c8eb5e440918f56f83bcfea9031.jpg, createdBy=3a345397082, createdName=Jessica, createdTime=Fri Mar 05 09:31:29 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945632, encodeId=30ac94563257, content=各保自身, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Fri Mar 05 09:02:36 CST 2021, time=2021-03-05, status=1, ipAttribution=)]
    2021-03-05 公卫新人

    新冠肺炎,疫情何时才能消失

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1677039, encodeId=c5aa16e70392e, content=<a href='/topic/show?id=206366e4077' target=_blank style='color:#2F92EE;'>#澳洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66740, encryptionId=206366e4077, topicName=澳洲)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8d027423047, createdName=huangdf, createdTime=Tue Jun 01 07:52:12 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950861, encodeId=f085950861a4, content=非常感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200815/567eec2d6b074163be1d5e1d9226b578/9c20a5fef2764c169c6ac9bf44997ee8.jpg, createdBy=7d5a5410735, createdName=Ably冰, createdTime=Wed Mar 24 21:44:35 CST 2021, time=2021-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1385476, encodeId=0ec213854e63c, content=<a href='/topic/show?id=c31c5322844' target=_blank style='color:#2F92EE;'>#意大利#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53228, encryptionId=c31c5322844, topicName=意大利)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ae503, createdName=pps20019, createdTime=Sat Mar 06 23:52:12 CST 2021, time=2021-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029185, encodeId=dd511029185a5, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Mar 05 11:52:12 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945649, encodeId=f3a4945649da, content=疫苗争夺战, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/df01a4bfb64246379ddfef3370d04115/e1274c8eb5e440918f56f83bcfea9031.jpg, createdBy=3a345397082, createdName=Jessica, createdTime=Fri Mar 05 09:31:29 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945632, encodeId=30ac94563257, content=各保自身, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Fri Mar 05 09:02:36 CST 2021, time=2021-03-05, status=1, ipAttribution=)]
    2021-03-05 Jessica

    疫苗争夺战

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1677039, encodeId=c5aa16e70392e, content=<a href='/topic/show?id=206366e4077' target=_blank style='color:#2F92EE;'>#澳洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66740, encryptionId=206366e4077, topicName=澳洲)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8d027423047, createdName=huangdf, createdTime=Tue Jun 01 07:52:12 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950861, encodeId=f085950861a4, content=非常感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200815/567eec2d6b074163be1d5e1d9226b578/9c20a5fef2764c169c6ac9bf44997ee8.jpg, createdBy=7d5a5410735, createdName=Ably冰, createdTime=Wed Mar 24 21:44:35 CST 2021, time=2021-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1385476, encodeId=0ec213854e63c, content=<a href='/topic/show?id=c31c5322844' target=_blank style='color:#2F92EE;'>#意大利#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53228, encryptionId=c31c5322844, topicName=意大利)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ae503, createdName=pps20019, createdTime=Sat Mar 06 23:52:12 CST 2021, time=2021-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029185, encodeId=dd511029185a5, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Mar 05 11:52:12 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945649, encodeId=f3a4945649da, content=疫苗争夺战, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/df01a4bfb64246379ddfef3370d04115/e1274c8eb5e440918f56f83bcfea9031.jpg, createdBy=3a345397082, createdName=Jessica, createdTime=Fri Mar 05 09:31:29 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945632, encodeId=30ac94563257, content=各保自身, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Fri Mar 05 09:02:36 CST 2021, time=2021-03-05, status=1, ipAttribution=)]
    2021-03-05 神盾医疗局局长Jack

    各保自身

    0

相关资讯

3.5亿美元,阿斯利康出售重磅药物Crestor欧洲权益

日前,据相关外媒报道,阿斯利康将其旗下重磅药物Crestor(瑞舒伐他汀钙,中文商品名:可定)在欧洲30多个国家(除开英国和西班牙)的权利出售给德国制药公司Gruenenthal,通过此次交易,阿斯利

阿斯利康的Tagrisso在美国被批准作为NSCLC的辅助疗法

FDA允许Tagrisso(osimertinib)治疗EGFR外显子19缺失或外显子21 L858R突变的非小细胞肺癌(NSCLC)患者。

​阿斯利康达格列净治疗慢性肾病适应症获FDA优先审评资格

1月6日,阿斯利康SGLT2(钠-葡萄糖协同转运蛋白2)抑制剂达格列净上市申请获FDA优先审评资格,用于治疗成人新确诊或恶化的慢性肾病(CKD),无论这些患者是否患有2型糖尿病(T2D)。达格列净有可

阿斯利康的COVID-19候选疫苗:有效率达70%

该结果意味着黑猩猩腺病毒改良版的新冠疫苗达到了试验的主要终点。

营销案例:小小便签,大大不同

最好的时候,肺癌的诊断和治疗就足够艰难了。 阿斯利康(AstraZeneca)的新运动旨在帮助患者进行这两种治疗,因为这是由于大流行而特别困难的时期。

对抗变异毒株是否有效?阿斯利康疫苗阶段性研究结果公开

英国阿斯利康制药公司6日证实,初步研究数据显示,阿斯利康研发的新冠疫苗对最初在南非发现的变异新冠病毒轻症感染者保护效力“有限”。不过,按照英国牛津大学研究人员的说法,这款疫苗对